Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?

Articles: Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-cirrhotic, Non-alcoholic Steatohepatitis (FLINT): a Multicentre, Randomised, Placebo-controlled Trial (Lancet 2015;385:956-965) Liraglutide Safety and Efficacy in Patients with Non-alcoholic Steatohepatitis (LEAN): a Multicentre, Double-blind, Randomised, Placebo-controlled Phase 2 Study (Lancet 2016;387:679-690)